Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Data(s) |
18/09/2008
|
---|---|
Resumo |
Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel. |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Sacco , R L , Diener , H-C , Yusuf , S , Cotton , D , Ounpuu , S , Lawton , W A , Palesch , Y , Martin , R H , Albers , G W , Bath , P , Bornstein , N , Chan , B P L , Chen , S-T , Cunha , L , Dahlöf , B , De Keyser , J , Donnan , G A , Estol , C , Gorelick , P , Gu , V , Hermansson , K , Hilbrich , L , Kaste , M , Lu , C , Machnig , T , Pais , P , Roberts , R , Skvortsova , V , Teal , P , Toni , D , Vandermaelen , C , Voigt , T , Weber , M , Yoon , B-W , PRoFESS Study Group & Passmore , P 2008 , ' Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke ' New England Journal of Medicine , vol 359 , no. 12 , pp. 1238-51 . DOI: 10.1056/NEJMoa0805002 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700 #Medicine(all) |
Tipo |
article |